Division of Cardiology, Azienda Ospedaliera-Universitaria "Maggiore Della Carità", Eastern Piedmont University, C.So Mazzini, 18, 28100 Novara, Italy.
J Thromb Thrombolysis. 2011 May;31(4):458-63. doi: 10.1007/s11239-010-0531-z.
Few reports have so far investigated the relationship between fibrinogen levels and the extent of coronary artery disease (CAD) as evaluated by coronary angiography, that is therefore the aim of the current study. We measured fibrinogen in 2,121 consecutive patients undergoing coronary angiography. Patients were divided in 5 groups based on quintiles of fibrinogen levels. Significant CAD was defined as stenosis >50% in at least 1 coronary vessel. We additionally measured carotid intima-media thickness (CIMT) in a subgroup of 359 patients. Patients with elevated fibrinogen were older (P = 0.038), with larger prevalence of diabetes (P = 0.027), female gender (P < 0.0001), hypertension (P < 0.001), chronic renal failure (P < 0.0001), previous CVA (P = 0.036), less often with family history of CAD (P = 0.019) and previous PCI (P < 0.0001), more often presenting with ACS (P < 0.0001), more often on nitrates (P < 0.0001), clopidogrel (P = 0.009) and diuretics (P < 0.0001). Fibrinogen levels were linearly associated with baseline glycaemia (P < 0.017), WBC count (P < 0.0001), creatinine (P < 0.0001), and Platelet count (P < 0.0001) but inversely associated with RBC count (P < 0.0001). Fibrinogen levels were associated with CAD (P = 0.001), especially for extremely high levels (5th percentile, P < 0.0001). At multivariate analysis, after correction for baseline confounding factors, high fibrinogen level (5th percentile) was still associated with the prevalence of CAD (P = 0.034). Furthermore, fibrinogen levels were related with maximal CIMT (r = 0.12; P = 0.01), with larger prevalence of carotid plaques in patients with higher fibrinogen levels (5th quintile) as compared to remaining patients (P = 0.046). This study showed that high fibrinogen level is significantly associated with CAD and carotid atherosclerosis.
目前的研究旨在探讨纤维蛋白原水平与冠状动脉疾病(CAD)严重程度的关系,此前鲜有相关报告。我们对 2121 例行冠状动脉造影术的连续患者进行了纤维蛋白原测量。患者根据纤维蛋白原水平的五分位数分为 5 组。有意义的 CAD 定义为至少 1 个冠状动脉血管狭窄>50%。我们还在 359 例患者亚组中测量了颈动脉内膜中层厚度(CIMT)。纤维蛋白原升高的患者年龄较大(P=0.038),糖尿病患病率较高(P=0.027),女性(P<0.0001)、高血压(P<0.001)、慢性肾功能衰竭(P<0.0001)、既往 CVA(P=0.036)、CAD 家族史较少(P=0.019)和 PCI 较少(P<0.0001),更常表现为 ACS(P<0.0001),更常使用硝酸盐(P<0.0001)、氯吡格雷(P=0.009)和利尿剂(P<0.0001)。纤维蛋白原水平与基线血糖(P<0.017)、白细胞计数(P<0.0001)、肌酐(P<0.0001)和血小板计数(P<0.0001)呈线性相关,但与红细胞计数呈负相关(P<0.0001)。纤维蛋白原水平与 CAD 相关(P=0.001),尤其是极高水平(第 5 个百分位,P<0.0001)。多变量分析后,校正基线混杂因素后,高纤维蛋白原水平(第 5 个百分位)仍与 CAD 的患病率相关(P=0.034)。此外,纤维蛋白原水平与最大 CIMT 相关(r=0.12;P=0.01),与纤维蛋白原水平较高的患者颈动脉斑块的患病率较高(第 5 个五分位数)与其余患者相比(P=0.046)。本研究表明,高纤维蛋白原水平与 CAD 和颈动脉粥样硬化显著相关。